Content about New Jersey

March 24, 2011

Four-in-5 menthol smokers would quit if the Food and Drug Administration banned mentholated cigarettes, according to a survey conducted this month with sponsorship from GlaxoSmithKline Consumer Healthcare.

PARSIPPANY, N.J. — Four-in-5 menthol smokers would quit if the Food and Drug Administration banned mentholated cigarettes, according to a survey conducted this month with sponsorship from GlaxoSmithKline Consumer Healthcare.

The survey found that smokers of menthol cigarettes — who are disproportionately African-American — feel “twice-addicted” to the menthol and the tobacco, while 74% of them said the menthol made inhalation easier, and 40% said menthol flavoring was the only reason they smoked.

March 22, 2011

A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

MORRISTOWN, N.J. — A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

Watson Labs launched famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir and is used to treat cold sores and genital herpes in patients with and without HIV.

Famvir and generic versions had sales of about $197 million in 2010, according to IMS Health.

March 18, 2011

An ice cream brand making its U.S. debut is at the forefront of a three-part film series starring Rachel Bilson.

ENGLEWOOD CLIFFS, N.J. — An ice cream brand making its U.S. debut is at the forefront of a three-part film series starring actress Rachel Bilson.

Magnum, a 20-year-old Unilever brand, said the films were directed by fashion guru Karl Lagerfeld and are a platform to introduce the premium ice cream products to U.S. consumers. The films, which will debut at the Tribeca Flm Festival, also can be viewed on the brand's Facebook page next month.

March 15, 2011

A generic painkiller made by Watson Pharmaceuticals does not infringe on the patent covering the branded version, a U.S. District Court has ruled.

MORRISTOWN, N.J. — A generic painkiller made by Watson Pharmaceuticals does not infringe on the patent covering the branded version, a U.S. District Court has ruled.

Watson said the U.S. District Court for the District of Delaware ruled that Watson’s generic version of Cephalon’s Fentora (fentanyl buccal tablets) does not infringe on two patents that were set to expire in March 2019, according to Food and Drug Administration records.

March 15, 2011

Unilever, the maker of Dove Men+Care, is celebrating the launch of its new Dove Men+Care antiperspirants/deodorants and Sensitive Clean personal wash by inking a corporate partnership with the National Collegiate Athletic Association.

ENGLEWOOD CLIFFS, N.J. — Unilever, the maker of Dove Men+Care, is celebrating the launch of its new Dove Men+Care antiperspirants/deodorants and Sensitive Clean personal wash by inking a corporate partnership with the National Collegiate Athletic Association.

March 10, 2011

The ridiculously long-lasting gum has tapped a snowboarding and skateboarding champion to serve as the brand's spokesman.

EAST HANOVER, N.J. — The ridiculously long-lasting gum has tapped a snowboarding and skateboarding champion to serve as the brand's spokesman.

Shaun White, an Olympic gold medalist, inked a two-year deal with Stride to be the gum's official brand spokesman and will be featured in a variety of promotional activities. Stride said it is planning giveaways, digital and social media campaigns, and public relations efforts throughout the coming months.

March 9, 2011

The Food and Drug Administration has accepted an approval application from Merck for a drug to treat eye diseases, Merck said Wednesday.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has accepted an approval application from Merck for a drug to treat eye diseases, Merck said Wednesday.

Merck is seeking approval for Saflutan (tafluprost) ophthalmic solution, an investigational drug for relieving eye pressure in patients with glaucoma and ocular hypertension.

March 9, 2011

The Food and Drug Administration has accepted a regulatory approval application from Tris Pharma for a drug to treat allergies in children ages 2 years and older, Tris said Wednesday.

MONMOUTH JUNCTION, N.J. — The Food and Drug Administration has accepted a regulatory approval application from Tris Pharma for a drug to treat allergies in children ages 2 years and older, Tris said Wednesday.

Tris said that if approved, its carbinoxamine extended-release oral suspension would provide an alternative to currently available immediate-release formulations.

March 9, 2011

Generic drug maker Watson Pharmaceuticals has promoted two executives to EVP, the company said Wednesday.

MORRISTOWN, N.J. — Generic drug maker Watson Pharmaceuticals has promoted two executives to EVP, the company said Wednesday.

The company gave the promotions to SVP, general counsel and secretary David Buchen and SVP and CFO R. Todd Joyce. Both will continue to report to CEO Paul Bisaro.

March 8, 2011

The Food and Drug Administration has accepted a regulatory approval application for a Type 2 diabetes drug from Bristol-Myers Squibb and AstraZeneca, the two drug makers said Tuesday.

PRINCETON, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a Type 2 diabetes drug from Bristol-Myers Squibb and AstraZeneca, the two drug makers said Tuesday.

The FDA accepted the application for dapagliflozin, an investigational drug for adults with the disease. The Centers for Disease Control and Prevention estimated that 1-in-11 U.S. adults has diabetes, with 90% to 95% of them having Type 2 diabetes.

The agency expects to take action on the application in late October.

March 7, 2011

Actavis last week named Lisa Buono to lead its over-the-counter drug division as part of the company’s strategic expansion of the division.

MORRISTOWN, N.J. — Actavis last week named Lisa Buono to lead its over-the-counter drug division as part of the company’s strategic expansion of the division.

As director of OTC, Buono will oversee the division’s day-to-day operations and will focus on identifying and capitalizing on new product opportunities. Actavis manufactures and distributes numerous nonprescription liquids, creams and ointments sold under the Actavis label and its customers’ own brands, as well as FeverAll brand acetaminophen suppositories.

March 7, 2011

Frank's RedHot is cooking up something spicy in the frozen food aisle.

PARSIPPANY, N.J. — Frank's RedHot is cooking up something spicy in the frozen food aisle.

Through a collaboration with Completely Fresh Foods, the hot sauce brand announced it was introducing fully cooked chicken wings, shrimp and appetizers that will be sold in grocery, mass and club stores nationwide. Frank's RedHot heat-and-serve offerings will include buffalo wings, buffalo shrimp, chicken fries and chicken poppers.

March 4, 2011

The Food and Drug Administration has approved a drug made by Eisai to treat a rare form of epilepsy, the drug maker said Friday.

WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a drug made by Eisai to treat a rare form of epilepsy, the drug maker said Friday.

The FDA approved Banzel (rufinamide) oral suspension for the treatment of seizures in children and adults with Lennox-Gastaut syndrome. The condition, also called LGS, affects 1% to 4% of children with epilepsy.

“This new formulation provides an option for patients who may prefer a liquid or find it difficult to take the medication in tablet form,” Eisai president and CEO Lonnel Coats said.

March 3, 2011

The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

BRIDGEWATER, N.J. — The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

The FDA approved indomethacin extended-release capsules in the 75-mg strength. The drug is used to treat pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, bursitis and tendonitis.

March 1, 2011

Consumer products company Scerene Healthcare is bringing its Puristics Totally Ageless skin care line to Walgreens on a regional basis in April.

PEAPACK, N.J. — Consumer products company Scerene Healthcare is bringing its Puristics Totally Ageless skin care line to Walgreens on a regional basis in April.

The collection is available in select markets at select retail locations, including Rite Aid, King Soopers and Harris Teeter. Beginning in April, the line also will be available in Walgreens in the Milwaukee, Madison, Wis., and Denver regions.

March 1, 2011

A New Jersey merchant was arrested on charges related to selling goods stolen from a local Rite Aid store, particularly cigarettes, according to published reports.

TRENTON, N.J. — A New Jersey merchant was arrested on charges related to selling goods stolen from a local Rite Aid store, particularly cigarettes, according to published reports.

The Trenton, N.J., Trentonian reported Tuesday that police arrested Ladislao Martinez and charged him with fencing stolen goods, organized retail theft and receiving stolen property, seizing cigarettes, paperwork and cash from his store, the MR Supermarket.

February 25, 2011

In his 2011-2012 budget, New York governor Andrew Cuomo included a proposal to update New York’s Medicaid program. The announcement comes at the heels of New Jersey governor Chris Christie's motion to modernize the state's Medicaid plan.

WASHINGTON — In his 2011-2012 budget, New York governor Andrew Cuomo included a proposal to update New York’s Medicaid program. The announcement comes at the heels of New Jersey governor Chris Christie's motion to modernize the state's Medicaid plan.

Similarly to New Jersey's plan, Cuomo said New York's “Proposal to Redesign Medicaid” could save state taxpayers $350 million though 2015 by managing prescription drug benefits similarly to those in Medicare and private-sector programs.

February 25, 2011

Savient said its newest drug is the first and only therapy available to treat chronic gout in adult patients refractory to conventional therapy.

EAST BRUNSWICK, N.J. — Savient said its newest drug is the first and only therapy available to treat chronic gout in adult patients refractory to conventional therapy.

The drug maker announced the U.S. commercial launch of Krystexxa (pegloticase).

February 24, 2011

Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.

PRINCETON, N.J. — Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.

The company submitted to the Food and Drug Administration its application for recombinant factor XIII compound, for congenital factor XIII deficiency. Current treatments for FXIII deficiency use products derived from human blood plasma, which carries the risk of contamination.

February 24, 2011

Generic drug maker Par Pharmaceutical Cos. had sales of $227 million during fourth quarter 2010 and $1 billion for the year as a whole, according to an earnings statement Thursday.

WOODCLIFF LAKE, N.J. — Generic drug maker Par Pharmaceutical Cos. had sales of $227 million during fourth quarter 2010 and $1 billion for the year as a whole, according to an earnings statement Thursday.

Profits were $17.5 million for the quarter and $92.7 million for the year, compared with $10.7 million in fourth quarter 2009 and $76.9 million for 2009 as a whole.

February 23, 2011

A group representing the nation's pharmacy benefit managers is responding to a proposal made by New Jersey governor Chris Christie that seeks to modernize the state's Medicaid program.

WASHINGTON — A group representing the nation's pharmacy benefit managers is responding to a proposal made by New Jersey governor Chris Christie that seeks to modernize the state's Medicaid program.

Christie said the proposed overhaul, which includes managing prescription drug benefits similarly to those in Medicare and private-sector programs, would save the state $41 million, “while still providing vital services,” the governor said.

February 23, 2011

The makers behind a popular Type 2 diabetes treatment have included data from two clinical studies in an update to the drug's prescribing information.

PRINCETON, N.J., and WILMINGTON, Del. — The makers behind a popular Type 2 diabetes treatment have included data from two clinical studies in an update to the drug's prescribing information.

Bristol-Myers Squibb and AstraZeneca said the Food and Drug Administration approved the labeling update for Onglyza (saxagliptin), which now includes efficacy and safety information about the drug's effects on patients with renal impairment or end-stage renal disease.

February 22, 2011

As the holiday season comes to a close, Mars Chocolate North America already is unveiling its winter holiday offerings for 2011.

HACKETTSTOWN, N.J. — As the holiday season comes to a close, Mars Chocolate North America already is unveiling its winter holiday offerings for 2011.

Mars said it is expanding its M&M's and Dove brands with seasonal candies that capture the holiday spirit, including new gifting displays for retailers.

New products include such items as M&M's stocking tin ornaments, which are filled with M&M’s milk chocolate candies, and Dove silky and smooth truffles, available in milk and dark chocolate.

February 22, 2011

Sales at Medco Health Solutions increased to $16.9 billion during fourth quarter 2010 and to $66 billion for the fiscal year as a whole, representing respective 11.1% and 10.3% increases over the same periods the year before, the pharmacy benefit manager said Tuesday.

FRANKLIN LAKES, N.J. — Sales at Medco Health Solutions increased to $16.9 billion during fourth quarter 2010 and to $66 billion for the fiscal year as a whole, representing respective 11.1% and 10.3% increases over the same periods the year before, the pharmacy benefit manager said Tuesday.

Profits for the quarter were $378.5 million, a 10.8% increase over fourth quarter 2009, while profits for the year were $1.4 billion, an 11.5% increase over fiscal year 2009.

February 18, 2011

NEW BRUNSWICK, N.J. — McNeil Consumer’s absence from cough-cold and analgesic aisles, including several pediatric formulations, will extend into the fourth quarter, Johnson and Johnson executives told analysts in January.